CAS number: 80474-14-2

General information about the Fluticasone Propionate active pharmaceutical ingredient

Fluticasone Propionate as active pharmaceutical ingredient (API) is a corticosteroid or steroid, class of glucocorticoid with anti-inflammatory actions. Fluticasone Propionate API is a glucocorticoid used to treat asthma, inflammatory pruritic dermatoses, and nonallergic rhinitis. Fluticasone Propionateis indicated as an inhaler for the treatment and management of asthma by prophylaxis as well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis. Fluticasone Propionate drugs are available as inhalers, nasal sprays, and topical treatments for various inflammatory indications. Fluticasone Propionate can be used in combination with Salmeterol Xinafoate(hyperlink).

Axplora manufactures Fluticasone Propionate API

Fluticasone Propionate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Fluticasone Propionate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Fluticasone Propionate API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Fluticasone Propionate API.
  • Therapeutic area Respiratory
  • Monograph PH.EUR.
  • Available grade Micronized
  • Regulatory documentation US DMF#
  • Produced in GRO